Frontiers in Nuclear Medicine

Aims & Scope

Frontiers in Nuclear Medicine is a multidisciplinary journal that advances the use of nuclear medicine in diagnostics and therapeutics as an essential part of patient care.

Led by Field Chief Editor Prof Adriaan A.

Lammertsma (University Medical Center Groningen, Netherlands) and an outstanding international editorial board, Frontiers in Nuclear Medicine publishes research that is dedicated to the application and development of nuclear medicine techniques for diagnostic and/or therapeutic purposes across all major subspecialties involved, including: • dosimetry and radiation safety • PET and SPECT • physics and data analysis • radiomics and artificial intelligence • radionuclide therapy • radiopharmacy and radiochemistry.

Frontiers in Nuclear Medicine welcomes research studies that include advances in technology, diagnostics studies, AI applied to image interpretation, as well as studies on radionuclide therapy.

In addition, the journal welcomes studies on the synthesis and evaluation of novel radiotracers, studies that aim to quantify radiotracer uptake, as well as novel multi-disciplinary and cross-disciplinary studies in nuclear medicine.

Finally, research and clinical practice of nuclear medicine in disciplines such as neurology, oncology, cardiology, and inflammatory diseases are encouraged, together with studies in which nuclear medicine methodology is used for drug development and precision medicine.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 1,950.00 CHF. Learn more.

Explore journals without APCs for alternative publishing options.